Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Amortization of Deferred Charges (2023 - 2026)

Compass Therapeutics' Amortization of Deferred Charges history spans 4 years, with the latest figure at -$206000.0 for Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges fell 892.31% to -$206000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$1.9 million, a 52.52% decrease, with the full-year FY2025 number at -$1.7 million, down 1.33% from a year prior.
  • Amortization of Deferred Charges hit -$206000.0 in Q1 2026 for Compass Therapeutics, up from -$1.2 million in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for CMPX hit a ceiling of $26000.0 in Q1 2025 and a floor of -$1.2 million in Q4 2025.
  • Historically, Amortization of Deferred Charges has averaged -$519692.3 across 4 years, with a median of -$376000.0 in 2024.
  • Biggest five-year swings in Amortization of Deferred Charges: soared 106.91% in 2025 and later crashed 892.31% in 2026.
  • Tracing CMPX's Amortization of Deferred Charges over 4 years: stood at -$812000.0 in 2023, then soared by 66.75% to -$270000.0 in 2024, then crashed by 342.96% to -$1.2 million in 2025, then soared by 82.78% to -$206000.0 in 2026.
  • Business Quant data shows Amortization of Deferred Charges for CMPX at -$206000.0 in Q1 2026, -$1.2 million in Q4 2025, and -$375000.0 in Q3 2025.